Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA begins data initiative with millions of adverse event reports

Will provide web developers and others with access to large public health datasets
575639

Web developers, researchers and the public will now have easier access to FDA public health datasets thanks to the US regulator's new open data initiative.

The openFDA project began this week with the release of millions of reports of drug adverse events and medication errors that have been submitted to the FDA between 2004 and 2013.

The data had previously been available, but only through a difficult-to-use reporting system or via Freedom of Information Act requests.

Taha Kass-Hout, the FDA's chief health informatics officer, said: "Through this new and novel approach to data organisation, these reports will be available in their entirety so that software developers can build tools to help signal potential safety information, derive meaningful insights, and get information to consumers and healthcare professionals in a timely manner.

"OpenFDA offers a scalable platform that can be easily searched and queried across many distinct datasets, and can be easily redeployed or altered to fit a variety of purposes, and provides an innovative public data search and analytics solution."

The first release of data will followed by the FDA's databases on product recalls and product labelling, with the whole project coming in the way of the Presidential Executive Order on Open Data and the Department of Health and Human Services' Health Data Initiative.

The openFDA website makes the FDA's publicly available data accessible in a structured, computer readable format through a search-based application program interface (API).

The regulator says this will make it possible for the likes of mobile application creators, web developers, data visualisation artists and researchers to quickly search and make use of public information contained in the FDA's datasets.

4th June 2014

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics